Dr. Omid Behnamfar, MD

Dr. Behnamfar practices at Acute Care Surgery Medical Group, Inc. in Sacramento, California.

Dr. Behnamfar's NPI, 1629507207, was assigned on June 7, 2017. Dr. Behnamfar graduated from Isfahan University of Medical Sciences in 2010. Dr. Behnamfar holds California license A169355.

Dr. Behnamfar's primary practice is Acute Care Surgery Medical Group, Inc., at 2800 L St, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 441-0400.

Dr. Behnamfar's primary practice is Acute Care Surgery Medical Group, Inc. in Sacramento, California. Dr. Behnamfar is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Behnamfar to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Behnamfar practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Behnamfar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Behnamfar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Behnamfar's licenses on file in 2 states: California and Illinois.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cerebrovascular disease, chronic hypertension, coronary artery disease, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Behnamfar treats.

CMS data shows 2,785 Medicare services from Dr. Behnamfar across 29 procedure codes in 2024, for 1,340 Medicare patients. Medicare paid $207,911 for them.

CMS counts 1,340 Medicare patients who saw Dr. Behnamfar in 2024. The largest group is 75 to 84, with 497 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Behnamfar's median patient age at 70, with 47% women.

In 2024, Dr. Behnamfar wrote 2,333 Medicare Part D claims for 413 patients. 83% of them were for generic drugs. CMS names the drug for 2,138 of them, across 30 drugs with 11 or more claims each, at $440,850 in total drug cost. In 2023, CMS named 386 claims across 12 drugs.

Dr. Behnamfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Behnamfar as offering telehealth.

Dmand AI links 16 papers to Dr. Behnamfar, published from 2015 to 2019. 2017 was the busiest year, with 6. The most frequent topics are Percutaneous Coronary Intervention, Coronary Artery Disease and Robotics. Dr. Behnamfar has published most often in Catheter Cardiovasc Interv. Dr. Behnamfar's most frequent co-authors are Ehtisham Mahmud, MD, Lawrence W. Ang, MD and Ryan Robert Reeves, MD.

CMS Open Payments shows 24 general payments to Dr. Behnamfar from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 80% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $597.

Dr. Behnamfar graduated from Isfahan University of Medical Sciences in 2010.

Dr. Behnamfar is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.